报 告 人：Xu Chenjie PhD（Nanyang Technological University, Singapore）
报告时间：2016年3月9日（星期三）上午10：30
报告地点：嘉定园区学术活动中心307室
报告人简介：
XuChenjie PhD
Assistant Professor, Division of Bioengineering
School of Chemical & Biomedical Engineering
Nanyang Technological University, Singapore
Dr. XU Chenjie received his B.S. from Nanjing University (2002, China), and M.Phil. from Hong Kong University of Science and Technology (2004, Hong Kong). After one year internship at Stanford University (2005), he continued his Ph.D. studyat Brown University (RI, 2005-2009). From 2009-2012, Dr. XU was a research associate at the Harvard-MIT Health Sciences and Technology (HST) Program and Harvard medical school. He joined Nanyang Technological University as an Assistant Professor in August 2012.
Key research areas: nanoparticle, contrast agent, cell labeling and tracking, molecular imaging, drug delivery, skin disease
报告摘要：
Owing to their size and unique chemical/physical properties, materials with nanostructures are an emerging class of material for biomedical applications. In recent times, the opportunities for nanomaterials in medicine have gone from potential to reality. There are now many prominent examples of nanomaterials being used to improve human health, ranging from diagnosis to therapy to regenerative medicine.
In this talk, Dr. Xu will discuss his effort in designing responsive nanoparticle-based nanosensors for tracking cells in cell therapy and delivering drugs to tissues that are hard to reach, and helping the scar treatment with microneedle technology. The goal of his research is to bridge the gap between fundamental science and biomedical opportunities.
